BILL vs BTAI · rev $1.65B vs rev $388.0K
Bill Com Holdings Inc (BILL) versus BioXcel Therapeutics Inc (BTAI) — a side-by-side from cached financials, not a winner call.
Bill Com Holdings Inc (BILL) is a software - application company listed on US.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BILL revenue for 2026-06-30 was $1.65B. Net income was -$11.2M. Revenue was up 13.0% from 2025-06-30 to 2026-06-30. BILL currently screens at market cap $4.78B.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
BILL currently screens at market cap $4.78B. BTAI currently screens at market cap $36.1M.
Not investment advice. Open the BILL and BTAI stock pages for the full models.
Not investment advice.